Increased cash balance and momentum with both Nasdaq and Phase 1 trial initiation mark strong beginning for 2025
CERo Therapeutics Holdings, Inc. Highlights Progress
Seeking Alpha / 2 hours from now 1 Views
Seeking Alpha / 2 hours from now 1 Views
Increased cash balance and momentum with both Nasdaq and Phase 1 trial initiation mark strong beginning for 2025
Comments